[Federal Register Volume 76, Number 108 (Monday, June 6, 2011)]
[Notices]
[Page 32367]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-13871]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-1999-D-0742 (formerly Docket No. 1999D-4396)]


Draft Guidance for Clinical Investigators, Industry, and FDA 
Staff: Financial Disclosure by Clinical Investigators; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
that appeared in the Federal Register of May 24, 2011 (76 FR 30175). 
The document announced the availability of a draft guidance entitled `` 
Draft Guidance for Clinical Investigators, Industry, and FDA Staff: 
Financial Disclosure by Clinical Investigators.''The document was 
published with an incorrect docket number. This document corrects that 
error.

FOR FURTHER INFORMATION CONTACT: Joyce Strong, Office of Policy, Food 
and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 3208, 
Silver Spring, MD 20993-0002, 301-796-9148.

SUPPLEMENTARY INFORMATION: In FR Doc. 2011-12623, appearing on page 
30175, in the Federal Register of Tuesday, May 24, 2011, the following 
correction is made:
    1. On page 30175, in the second column, in the Docket No. heading, 
``[Docket No. FDA-1999-D-0792] (Formerly FDA-1999-D-0792)'' is 
corrected to read ``[Docket No. FDA-1999-D-0742] (formerly Docket No. 
1999D-4396)''.

    Dated: May 31, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011-13871 Filed 6-3-11; 8:45 am]
BILLING CODE 4160-01-P